CVS Health tops profit estimates as new CEO pursues turnaround; shares surge
CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met expectations, hinting at an
CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met expectations, hinting at an
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their impact on cost pressures in its health insurance
Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic competition for some of its
The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and activists.
Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that
UnitedHealth is expected to record higher medical costs in its first earnings report since a cyberattack disrupted its technology systems including those that manage
Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low
The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised
Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health
Boston Scientific will buy Silk Road Medical in a $1.16 billion deal, the company said on Tuesday, adding medical devices used for stroke prevention.
Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting
Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and
The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a
UnitedHealth forecast on Tuesday a bigger hit to annual earnings from a February hack at its tech unit, but maintained its full-year profit
Elevance Health signaled medical costs would remain high this year as the insurer expects more claims in the second half from members enrolled in its
Centene Corp said on Friday it expects medical costs to improve next year as states catch up with reassessment of enrollments for its Medicaid plans that
Humana said on Wednesday that demand for medical care was higher than it had anticipated in the second quarter, dampening investor hopes that elevated costs in the Medicare
CVS Health said on Wednesday that high demand for medical care among older adults hit second-quarter results, a trend that continued into July,
Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days to stop the promotion of the compounded versions of its drugs
Smaller rivals to UnitedHealth's tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily
Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
Your subscription has been successfully upgraded!